[1]
Modi, J. 2026. Elagolix as an oral substitute for injectable GnRH antagonists in IVF: a review and recent developments . International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 15, 11 (Oct. 2026), 4693–4697. DOI:https://doi.org/10.18203/2320-1770.ijrcog20264038.